Mark E. Skillan, MD Vice President & Medical Director, Munich American Re

Whether or not your company currently offers products tailored to the “mature age” market, demographic trends will require most companies to consider offering coverage to older age applicants in the future. Given the heterogeneity within the older age applicant pool, appropriate risk assessment of this population requires knowledge of key morbidity and mortality risk indicators. This talk will define “mature age”, discuss the aging process, and offer an overview of helpful tools for morbidity and mortality risk assessment for the older age applicant.